自身免疫性疾病:目标,生物学和药物发现
Shu-Jie Li1,2, Yan-Li Wu3, Juan-Hua Chen3
1State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. lishujie@simm.ac.cn.
Acta pharmacologica Sinica
|December 14, 2023
概括
自身免疫性疾病是由失败的自我容忍造成的. 针对特定的自身抗原,如1型糖尿病 (T1D) 中的胰岛素,为超越当前症状治疗的有效免疫疗法提供了一个有希望的途径.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 自身免疫性疾病的发病因子
背景情况:
- 自身免疫性疾病 (AID) 源于免疫性自我耐受性丧失,导致免疫系统攻击身体自身的组织.
- 目前对艾滋病的治疗主要涉及非特异性免疫抑制,仅提供症状缓解,并产生高成本.
- 识别特定的自身抗原对于开发针对性治疗来解决艾滋病的根本原因至关重要.
研究的目的:
- 根据潜在原因和相关的自身抗原来对自身免疫性疾病进行分类.
- 为各种AIDs所涉及的自身抗原提供全面的概述.
- 探索针对艾滋病的自身抗原向免疫疗法的潜力,重点关注1型糖尿病 (T1D).
主要方法:
- 审查和对有关自身免疫性疾病及其自身抗原的现有文献进行分类.
- 详细检查1型糖尿病 (T1D) 病原和胰岛素作为潜在自身抗原的作用.
- 对当前T1D治疗方法的分析和对新型免疫疗法策略的探索.
主要成果:
- 一个基于致病机制和已识别的自身抗原的AIDs分类框架.
- 证据支持胰岛素作为T1D病变发生的关键自身抗原的作用.
- 识别当前对AID的理解和治疗方法的差距.
结论:
- 针对特定的自身抗原代表了对自身免疫性疾病治疗的范式转变.
- 开发专注于胰岛素等自身抗原的免疫疗法对T1D具有重大前景.
- 对自身抗原鉴定和向治疗的进一步研究对于推进自身免疫性疾病管理至关重要.
相关概念视频
01:29Autoimmune Disorders
447
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
447
01:26Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
01:26Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
01:24Principles of Drug Action
6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
142
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
142